What is more, it has been reported that Beclin1 was up-regulated in 67.7% of NSCLC patients, and was suggested that high Beclin-1 expression predicts longer survival in locally advanced NSCLC (Lee et al., 2019). The gene discussed is BECN1; the disease is non-small cell lung carcinoma.